iPSC-Derived Cardiomyocyte Cell Line from Japan
Induced pluripotent stem cell (iPSC)-derived cardiomyocytes grown in specialized media for cardiac repair therapies and drug toxicity testing. Classified under HTS 3002.59.00.00 as modified cell cultures for therapeutic uses, obtained through biotechnological reprogramming. These are used in clinical trials for heart disease treatments.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Maintain cryopreservation logs and viability assays; use insulated shipping for live cells
• Declare genetic modification status and source (human/animal) accurately on commercial invoice